Razak Pharmaceutical Company (DRAZAK) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DRAZAK
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 25,209,785 | 10,121,663 | 5,974,093 | 5,356,469 | 6,451,824 | 4,905,579 |
| Cost of operating revenue | -11,261,053 | -6,911,907 | -4,131,001 | -3,915,543 | -3,550,635 | -2,813,024 |
| Gross profit (loss) | 13,948,732 | 3,209,756 | 1,843,092 | 1,440,926 | 2,901,189 | 2,092,555 |
| Selling, general and administrative expenses | -722,034 | -448,037 | -287,712 | -317,910 | -233,049 | -185,675 |
| Other income | 15,028 | 1,856 | 9,965 | 11,029 | 12,517 | 8,240 |
| Other expenses | -442 | -157,333 | -499,502 | -358,281 | -40,371 | -7,243 |
| Operating profit (loss) | 13,241,284 | 2,606,242 | 1,065,843 | 775,764 | 2,640,286 | 1,907,877 |
| Finance costs | -1,010,915 | -1,471,448 | -768,646 | -781,618 | -741,091 | -615,516 |
| Other non-operating income and expenses | 1,091,133 | 340,213 | 3,110 | 41,173 | 7,641 | 820,565 |
| Profit (loss) from continuing operations before tax | 13,321,502 | 1,475,007 | 300,307 | 35,319 | 1,906,836 | 2,112,926 |
| Current year tax | -1,954,962 | -121,344 | -66,713 | 0 | -427,634 | -258,947 |
| Net profit (loss) from continuing operations | 11,366,540 | 1,353,663 | 233,594 | 35,319 | 1,479,202 | 1,818,979 |
| Net profit (loss) | 11,366,540 | 1,353,663 | 233,594 | 35,319 | 1,479,202 | 1,818,979 |
| Basic earnings (loss) per share | 652 rials | 78 rials | 111 rials | 17 rials | 1,668 rials | 2,045 rials |
| Net earnings (loss) per share, rials | 653 rials | 78 rials | 112 rials | 17 rials | 1,663 rials | 2,045 rials |
| Capital | 17,429,992 | 17,429,992 | 2,100,000 | 2,100,000 | 889,500 | 889,500 |
Reporting periods
92 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.